Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536963 · ClinicalTrials.gov registry record
Improving Quality Vision Outcomes in Managed Care Setting While Reducing Cost by Use of Accurate, Automated Screening
A clinical trial, sponsored by Rebiscan.
- Completed
- Registry status
- 318
- Enrollment target
NCT02536963 is a clinical trial that has completed, run by Rebiscan. The registered enrollment target is 318 participants.
The verdict
NCT02536963 has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- 318 participants
- Enrollment target
Study Summary
Amblyopia ("lazy eye") and strabismus (misaligned eyes) are medical eye conditions that combine as the leading causes of preventable vision loss in children. They are irreversible if not detected and corrected by the age of seven, however half of all cases are missed because the conditions do not always manifest themselves and pediatricians are unable to reliably detect the conditions. The current health care system badly needs an accurate and effective approach toward detecting amblyopia and strabismus in preschool children. The study will be conducted in busy, ethnically and racially diverse primary care sites operated by the Kaiser Permanente system and compare the outcomes of testing with a Pediatric Vision Scanner with outcomes the current standard of care.
Interventions
- DEVICE Pediatric Vision Scanning device
- OTHER Reference examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02536963
The ClinicalTrials.gov registry entry for NCT02536963 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rebiscan, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pediatric Vision Scanning device is the first listed.
NCT02536963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02536963 about?
NCT02536963 is a clinical study titled "Improving Quality Vision Outcomes in Managed Care Setting While Reducing Cost by Use of Accurate, Automated Screening". Amblyopia ("lazy eye") and strabismus (misaligned eyes) are medical eye conditions that combine as the leading causes of preventable vision loss in children. They are irreversible if not detected and corrected by the age of seven, however half of all cases are missed because the conditions do not al...
What is the current status of trial NCT02536963?
This trial is currently completed. The enrollment target is 318 participants. The study started on 2016-01. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02536963?
The interventions under investigation include: Pediatric Vision Scanning device (DEVICE), Reference examination (OTHER).
Who is sponsoring clinical trial NCT02536963?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.